Skip Navigation U.S. Department of Health and Human Services
Agency for Healthcare Research Quality
Archive print banner

Slide Presentation from the AHRQ 2007 Annual Conference

This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: Let us know the nature of the problem, the Web address of what you want, and your contact information.

Please go to for current information.

Perceived Benefits to Providers

Text Description is below the image.

N=19 Before Participation
Mean (SD)
Today Mean (SD) Paired Difference Mean (SD) p-value
1. Ability to identify suitable candidates for treatment for HCV. 3.2 (1.3) 5.7 (0.8) 2.5 (1.0) <0.0001
2. Ability to assess severity of liver disease in patients with Hepatitis C. 3.7 (1.0) 5.6 (0.8) 1.9 (0.9) 0.0001
3. Ability to treat HCV patients and manage side effects. 2.3 (1.3) 5.5 (0.8) 3.2 (1.5) <0.0001

Scale: 1 = none or no skill at all 7 = expert-can teach others.

Previous Slide Previous Slide         Contents         Next Slide Next Slide


The information on this page is archived and provided for reference purposes only.


AHRQ Advancing Excellence in Health Care